We found that circZNF609 was downregulated in silica-inhaled mouse lung tissue and TGF-β1-treated activated fibroblasts, suggesting the underlying clinical relevance of circZNF609 in lung fibrosis. This evidence concerns the gene TGFB1 and pulmonary fibrosis.